| Geographical Index
| Specialty Index
One Thompson Square, #503, Boston, MA 02129
Strategic communications including public relations, investor relations and corporate communications, as well as marketing and digital communications.
Employees: 15. Founded: 2001.
Lisa DeScenza, asst. VP, integrated comms.; Douglas Russell, sr. VP & gen. mgr.; Donna LaVoie, pres. & CEO, Paul Sagan, asst. VP, IR & corp. comms.; Ella Deych, VP, finance & opers.; and Sharon Correia, sr. VP, integrated comms.
LaVoieHealthScience is a health science focused, award winning integrated communications agency providing IR and PR bringing 18 years of industry-tested counsel to more than 375 clients. Our specialized expertise in biotechnology and pharmaceuticals, medical technology and devices, and digital and public health uniquely positions us to help clients make their health and science innovations known, understandable, and approachable to target stakeholders through carefully executed strategies and plans.
The agency has received over 50 awards in recognition of the work it has done for emerging and established industry leaders helping our clients from development to launch to commercialization. We help advance health and science innovations by providing specialized thinking to clients throughout the company and product life cycle building innovation and value for human kind. We offer direct connections to media, investors, partners, advocacy groups, and KOLs. We are focused on building trust and long-term relationships based on the quality of the work that we deliver. Many of our client relationships go back over a decade.
Donna L. LaVoie, pres. & CEO; Douglas Russell, sr. VP & gen. mgr.; Sharon Correia, sr. VP, integrated comms.; Sharon Choe, sr. VP, IR & BD; Paul Sagan, asst. VP, IR & corp. comms.; Lisa DeScenza, asst. VP, integrated comms.; Ella Deych, VP, finance & opers.
Clients Include: Select Clients:
AC Immune SA
Biotechnology Innovation Organization
LEO Science & Tech Hub
Life Sciences Corridor
Newron Pharmaceuticals SpA
SIRION Biotech GmbH
Symbiotix Biotherapies, Inc.